南卫股份(603880) - 2025 Q4 - 年度业绩预告

Financial Performance - The company expects a net loss of 80 million yuan for the fiscal year 2025, with a net profit attributable to the parent company after deducting non-recurring gains and losses projected at -82 million yuan [3]. - In the same period last year, the total profit was -200.86 million yuan, with a net profit attributable to the parent company of -190.67 million yuan, and a net profit after deducting non-recurring gains and losses of -187.73 million yuan [4]. - The earnings per share for the previous year was -0.66 yuan [4]. Operational Challenges - The poor performance in 2025 is primarily due to the underutilization of production capacity in the subsidiary's nitrile glove business, which was adversely affected by the industry market environment [7]. Earnings Forecast - The company emphasizes that the earnings forecast is based on preliminary calculations by the finance department and has not been audited by certified public accountants [9]. - There are no significant uncertainties affecting the accuracy of this earnings forecast as of the announcement date [8]. - The company advises investors to make cautious decisions and be aware of investment risks due to the preliminary nature of the financial data [9].

Jiangsu Nanfang Medical-南卫股份(603880) - 2025 Q4 - 年度业绩预告 - Reportify